Gentle, powerful, and efficient microencapsulation
compatible with live cells, biomolecules, and sensitive APIs
low shear stress
no toxic solvents
no pre-treatment
high precision
high throughput
high efficiency
A revolution in microparticle production:
IN-AIR MICROFLUIDICS™
Our patented IN-AIR MICROFLUIDICS™ technology combines microfluidic precision with industrial scalability. Using micrometer-sized liquid jets in mid-air, we create uniform microparticles, microcapsules, and even microfibers from 30µm to 3mm.
This chip-free, high-throughput platform enables gentle microencapsulation for life science, biopharma, and consumer care applications. Even delicate compounds like live stem cells, peptides, probiotics, and antioxidants retain their viability and potency, delivering results beyond conventional encapsulation methods.
Picture of IamFluidics' microparticle production using the patented IN-AIR MICROFLUIDICS™ jetting system.
Discover
IN-AIR MICROFLUIDICS™
encapsulation technology
The need for performance, speed,
and gentle microencapsulation
It all started with two visionary scientists working with stem cell encapsulation for their academic research at the University of Twente, in The Netherlands.
Frustrated with the slow throughput, limited efficiency, and the interference of chemicals when using chip-based microfluidics, they invented a new technology called IN-AIR MICROFLUIDICSÂ that was internationally awarded and published in high-impact scientific journals.
Our patented technology uses ink-jetting principles to encapsulate liquids in the air with high precision, control, and speed to produce state-of-the-art microparticles for batches of grams to multi-ton volumes using energy-efficient processes and sustainable materials.
Dr. Claas Willem Visser and Dr. Tom Kamperman,
IamFluidics' co-founders.
We develop sustainable microencapsulation solutions to address performance and scalability challenges with formulations, active ingredients, live cells, and biologicals.
Advanced formulations
Our unique process technology creates new possibilities to improve product performance, develop natural formulations without microplastics, and remove toxic chemicals from production.Â
​Originally invented for biological applications, our technology has the potential to revolutionize healthcare products where microparticles can be used to enable controlled drug delivery, microbiome therapies, living cells, tissue regeneration, and cellular agriculture applications.
Elevating performance
with monodisperse microparticles
Monodisperse microparticles present uniform size and shape, which improves encapsulation stability, efficiency, performance, sensory experience, ingestibility, and flowability, optimizing release kinetics for drug delivery.Â
​One of the main challenges around monodispersity is related to the low precision of high-volume encapsulation methods and low volumes of monodisperse particle production with traditional chip microfluidics.Â
​Our revolutionary in-air microfluidics technology is able to combine high throughput with high precision for sustainable production of monodisperse microparticles at an industrial scale, with size, shape, and material versatility.
Microscope picture of IamFluidics' monodisperse PLGA microparticles of 40µm
Material versatility and customization